Sign up to save your podcasts
Or
Share A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
280280 ratings
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
323 Listeners
Practical Neurology Podcast
48 Listeners
JAMA Clinical Reviews
500 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,138 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
192 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Neurology Exam Prep Podcast
185 Listeners
The Curious Clinicians
374 Listeners
Continuum Audio
80 Listeners